• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类大脑早期发育过程中注意力缺陷多动障碍风险基因的鉴定

Identification of Risk Genes for Attention-Deficit/Hyperactivity Disorder During Early Human Brain Development.

作者信息

Deng Ming-Gang, Zhou Xiuxiu, Li Xiaoyan, Liu Jiewei

机构信息

Wuhan Mental Health Center, Wuhan, Hubei, China; Wuhan Hospital for Psychotherapy, Wuhan, Hubei, China.

Anhui University, Hefei, Anhui, China.

出版信息

J Am Acad Child Adolesc Psychiatry. 2024 Nov 5. doi: 10.1016/j.jaac.2024.10.013.

DOI:10.1016/j.jaac.2024.10.013
PMID:39510315
Abstract

OBJECTIVE

Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder with high heritability. A total of 27 genome-wide significant loci for ADHD were previously identified through genome-wide association studies (GWASs), but the identification of risk genes that confer susceptibility to ADHD has remained largely unexplored.

METHOD

As ADHD is a neurodevelopmental disorder, we integrated human brain prenatal gene and transcript expression weight data (n = 120) and ADHD GWAS summary statistics (n = 225,534; 38,691 cases and 186,843 controls) to perform a transcriptome-wide association study (TWAS) by FUSION (an analytic suite).

RESULTS

Our analysis identified 10 genes, including LSM6, HYAL3, METTL15, RPS26, LRRC37A15P, RP11-142I20.1, ABCB9, AP006621.5, AC000068.5, and PDXDC1, that are significantly associated with ADHD, along with 8 transcripts of 7 genes. We also conducted TWAS analysis using CommonMind Consortium (CMC) adult brain gene and gene-splicing expression weights (n = 452), which highlighted several risk genes that showed associations with ADHD in both prenatal and postnatal stages, such as LSM6 and HYAL3.

CONCLUSION

Overall, our TWAS of ADHD, by integrating human prenatal brain transcriptome and ADHD GWAS results, uncovered the cis-effects of gene/transcript regulation that are predicted to be associated with ADHD. By combining colocalization and FOCUS fine-mapping analysis, we further unraveled potential causal candidate risk genes. The risk genes/transcripts that we identified in this study can serve as a valuable resource for further investigation of the disease mechanisms underlying ADHD.

摘要

目的

注意力缺陷多动障碍(ADHD)是一种常见的具有高遗传性的神经发育障碍。此前通过全基因组关联研究(GWAS)共鉴定出27个与ADHD相关的全基因组显著位点,但对导致ADHD易感性的风险基因的鉴定在很大程度上仍未得到充分探索。

方法

由于ADHD是一种神经发育障碍,我们整合了人类大脑产前基因和转录本表达权重数据(n = 120)以及ADHD的GWAS汇总统计数据(n = 225,534;38,691例病例和186,843例对照),通过FUSION(一种分析套件)进行全转录组关联研究(TWAS)。

结果

我们的分析确定了10个基因,包括LSM6、HYAL3、METTL15、RPS26、LRRC37A15P、RP11 - 142I20.1、ABCB9、AP006621.5、AC000068.5和PDXDC1,它们与ADHD显著相关,还有7个基因的8个转录本。我们还使用CommonMind联盟(CMC)的成人大脑基因和基因剪接表达权重(n = 452)进行了TWAS分析,这突出了几个在产前和产后阶段均与ADHD相关的风险基因,如LSM6和HYAL3。

结论

总体而言,我们通过整合人类产前大脑转录组和ADHD的GWAS结果进行的ADHD的TWAS,揭示了预计与ADHD相关的基因/转录本调控的顺式效应。通过结合共定位和FOCUS精细定位分析,我们进一步揭示了潜在的因果候选风险基因。我们在本研究中鉴定出的风险基因/转录本可作为进一步研究ADHD潜在疾病机制的宝贵资源。

相似文献

1
Identification of Risk Genes for Attention-Deficit/Hyperactivity Disorder During Early Human Brain Development.人类大脑早期发育过程中注意力缺陷多动障碍风险基因的鉴定
J Am Acad Child Adolesc Psychiatry. 2024 Nov 5. doi: 10.1016/j.jaac.2024.10.013.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Transdiagnostic and Diagnosis-Specific Morphological Similarity Related Transcriptional Profile in Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder.注意缺陷多动障碍和自闭症谱系障碍中与跨诊断及特定诊断形态相似性相关的转录谱
J Am Acad Child Adolesc Psychiatry. 2024 Nov 26. doi: 10.1016/j.jaac.2024.11.015.
4
Short-Term Memory Impairment短期记忆障碍
5
Bupropion for attention deficit hyperactivity disorder (ADHD) in adults.安非他酮用于治疗成人注意力缺陷多动障碍(ADHD)。
Cochrane Database Syst Rev. 2017 Oct 2;10(10):CD009504. doi: 10.1002/14651858.CD009504.pub2.
6
Stimulant and non-stimulant drug therapy for people with attention deficit hyperactivity disorder and epilepsy.兴奋剂和非兴奋剂药物治疗注意缺陷多动障碍和癫痫患者。
Cochrane Database Syst Rev. 2022 Jul 13;7(7):CD013136. doi: 10.1002/14651858.CD013136.pub2.
7
Integrating Genetic and Single-Cell Genomic Data to Reveal Brain Cell-Specific Regulation of Attention-Deficit/Hyperactivity Disorder Risk in the Prefrontal Cortex.整合遗传和单细胞基因组数据以揭示前额叶皮质中注意力缺陷多动障碍风险的脑细胞特异性调控
Brain Behav. 2025 Jul;15(7):e70664. doi: 10.1002/brb3.70664.
8
Integrative multi-omics data from early development to identify the genes and cell types underlying attention-deficit/hyperactivity disorder.整合从早期发育阶段获取的多组学数据,以确定注意力缺陷多动障碍背后的基因和细胞类型。
BMC Psychiatry. 2025 Jul 30;25(1):741. doi: 10.1186/s12888-025-07209-0.
9
Characterizing genetic pathways unique to autism spectrum disorder at multiple levels of biological analysis.在多个生物学分析层面上,对孤独症谱系障碍特有的基因通路进行特征描述。
Mol Autism. 2024 Oct 15;15(1):46. doi: 10.1186/s13229-024-00624-2.
10
Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.用于治疗儿童和青少年注意力缺陷多动障碍(ADHD)的哌甲酯——非随机研究中不良事件的评估
Cochrane Database Syst Rev. 2018 May 9;5(5):CD012069. doi: 10.1002/14651858.CD012069.pub2.

引用本文的文献

1
Unraveling ADHD: genes, co-occurring traits, and developmental dynamics.解读注意力缺陷多动障碍:基因、共病特征及发育动态
Life Sci Alliance. 2025 Feb 25;8(5). doi: 10.26508/lsa.202403029. Print 2025 May.